|
Mitsubishi Tanabe bags NeuroDerm and its PhIII Parkinson's program for $1.1B - Endpoi
https://www.neurotalk.org//t1.gstati...nu0o9zAdRrhHxe
Endpoints News <img alt="" height="1" width="1"> Mitsubishi Tanabe bags NeuroDerm and its PhIII Parkinson's program for $1.1B Endpoints News The Japanese pharma company agreed to pay $1.1 billion for the biotech, which has been developing a lead program for continued dosing of levodopa/carbidopa for Parkinson's patients. That's $39 a share, or a 79% premium over the unaffected early June ... Mitsubishi Tanabe to Buy Parkinson's Disease Drugs Firm NeuroDerm for $1.1BGenetic Engineering & Biotechnology News Mitsubishi Tanabe Coughs Up $1.1 Billion Cash for Parkinson's Biotech NeuroDermPharmaLive (press release) (subscription) Why NeuroDerm Ltd Acquired a Higher Price TodayMadison.com PMLiVE -Medical Xpress -The Jewish Press - JewishPress.com all 33 news articles » More... |
| All times are GMT -5. The time now is 04:35 AM. |
Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.